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� CORRESPONDENCE �
In their paper published in J Korean Med Sci entitled ‘‘Screen-
ing for Chlamydia and gonorrhea by strand displacement
amplification in homeless adolescents attending youth shel-
ters in Korea’’, Lee et al. demonstrated that the prevalence
of Chlamydia trachomatis among homeless adolescents was
12.6% (1). They reported a higher rate (28.1%) of infection
among sexually active adolescents than in a sexually inactive
group. In our study, to recognize the global importance of
sexually transmitted infections (STI) among teenage girls in
Upper Silesia we investigated 48 non-pregnant, sexually
active girls aged 16-19, living in an urban area, who paid a
visit for periodical check-up during oral contraceptive use.
The majority of the adolescents reported periodical mild pain
in the lower abdominal area and an increased amount of mucous
discharge. They also reported early first sexual unprotected
intercourse (<16 yr of age) and more than three sexual part-
ners. We used direct immunofluorescence assay for C. tra-
chomatis antigen detection (Chlamydia Direct IF, bioMerieux,
France) and obtained a high prevalence (27%) of C. trachomatis
infection.
C. trachomatis infection is the most common bacterial STI,
however, up to 70% of such infections are asymptomatic (2).
The detection of asymptomatic infection has an important
epidemiological implication, because the main consequences
(infertility, ectopic pregnancy, pelvic inflammatory disease,
and perinatal infections) of symptomatic and asymptomatic
infections are often identical. In regions where an early screen-
ing program for detection of C. trachomatis infection has been
established, the prevalence of infection in women is low: among
Norwegian girls aged between 16-19 yr C. trachomatis infec-
tion was confirmed only in 9% (3).
Testing for C. trachomatis in teenage girls is not routinely
performed in many countries (including Poland). Cook et al.
(4) found that only one-third of physicians carries out C. tra-
chomatis tests in asymptomatic, sexually active teenage women
during a routine gynecologic examination.
In our previous study (5) of 205 sexually active women
aged 17-40, we demonstrated a significant decrease of C. tra-
chomatis infection among women younger than 25. British
authors described 12.1% chlamydial infections in the age
group of girls aged 16-19, 8.8% in the age group 20-24, and
only 7.5% in the group younger than 16 (6). 
It is well known that human papilloma virus (HPV) is a
proliferative virus, replicating only in actively dividing cells.
The coexistence of bacterial infection (including C. trachomatis)
may potentiate the proliferation and replication (7, 8). More-
over, C. trachomatis infection may be a possible cofactor of
HPV infection, playing a major role in the etiology of cervi-
cal intraepithelial neoplasia. For this reason in our study group
of teenage girls we also detected HPV DNA in collected cer-
vical brushes using the Hybrid Capture I HPV Assay (Digene
Corp. Beltsville, MD, U.S.A.), with complimentary probes
for low oncogenic (6/11/42/43/44) and high oncogenic types
(16/18/31/33/35/45/51/52/56). The collected cervical swabs
were also assessed using the 2001 Bethesda System. HPV
DNA was detected only in 2 cases with a normal cytology.
Low grade squamous intraepithelial lesions (LSIL) was des-
cribed in 5 cases out of 48, all of which were HPV DNA-
negative, however 4 were C. trachomatis-positive. The role of
C. trachomatis in the development of cervical dysplasia is still
controversial. Antilla et al. (9), and Koskela et al. (10) con-
sidered an independent role of C. trachomatis in pathogenesis
of cervical intraepithelial dysplasia. Our results, obtained on
a small group of girls in Upper Silesia, were concordant with
the above conclusion, however, further studies on larger group
of adolescent girls are required to confirm this hypothesis.
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